<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77308">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02005445</url>
  </required_header>
  <id_info>
    <org_study_id>F1351-P</org_study_id>
    <nct_id>NCT02005445</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation</brief_title>
  <official_title>Obstructive Sleep Apnea Treatment to Improve Cardiac Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Department of Veterans Affairs</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized clinical trial in U.S. veterans to evaluate the impact of treatment for
      obstructive sleep apnea (OSA) on the effectiveness of cardiac rehabilitation, including
      impact on exercise capacity, disability, and quality of life.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea (OSA) is a highly prevalent condition in patients with coronary
      heart disease and is associated with impaired exercise performance, functional limitation
      and reduced health-related quality of life. We hypothesize that identification and treatment
      of OSA in patients undergoing cardiac rehabilitation will improve the response to
      rehabilitation. The proposed study will test this hypothesis using a parallel group,
      randomized, clinical trial comparing OSA treatment with continuous positive airway pressure
      (CPAP) to an educational control group in patients undergoing cardiac rehabilitation who
      screen positive for previously undiagnosed OSA.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Peak O2 consumption on cardiopulmonary exercise testing</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Peak O2 consumption on cardiopulmonary exercise testing</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous positive airway pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HLSE</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Healthy living and sleep education</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Continuous positive airway pressure</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HLSE</intervention_name>
    <description>Healthy living and sleep education</description>
    <arm_group_label>HLSE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veterans referred for cardiac rehabilitation at the VA Boston Healthcare System.

          -  Moderate to severe OSA (AHI &gt;15) on home sleep testing.

        Exclusion Criteria:

          -  Dangerous levels of sleepiness (Epworth Sleepiness Scale score &gt;16 or a report of
             falling asleep at the wheel of a car within the past 2 years).

          -  Physical limitation precluding exercise testing.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel J. Gottlieb, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel J Gottlieb, MD MPH</last_name>
    <phone>(857) 203-6375</phone>
    <email>daniel.gottlieb@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniel J Gottlieb, MD MPH</last_name>
      <phone>857-203-6375</phone>
      <email>daniel.gottlieb@va.gov</email>
    </contact>
    <investigator>
      <last_name>Daniel J. Gottlieb, MD MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 3, 2014</lastchanged_date>
  <firstreceived_date>December 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Coronary heart disease</keyword>
  <keyword>Cardiac rehabilitation</keyword>
  <keyword>Cardiopulmonary exercise testing</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
